NovoMix 30

DRUG3 trials

Sponsors

Rijnstate Hospital, Abertawe Bro Morgannwg University NHS Trust, Geropharm

Conditions

Diabetes MellitusDiabetes Mellitus Type IIDiabetes Mellitus, Type 2Latent Autoimmune Diabetes in Adults LADA

Phase 3

LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

CompletedNCT00151697

Rijnstate HospitalDiabetes Mellitus Type II

Start: 2005-05-31Target: 150Updated: 2011-08-09

Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

GeropharmDiabetes Mellitus, Diabetes Mellitus, Type 2

Start: 2020-01-20End: 2020-12-25Target: 264Updated: 2020-04-15

Unknown Phase

Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)

Abertawe Bro Morgannwg University NHS TrustLatent Autoimmune Diabetes in Adults LADA

Start: 2007-04-30End: 2011-04-30Target: 200Updated: 2008-10-21